Lemaitre Vascular (LMAT) Tops Q4 EPS by 3c, Beats on Revenue; Offers FY25 Guidance

Lemaitre Vascular (NASDAQ: LMAT) reported Q4 EPS of $0.49, $0.03 better than the analyst estimate of $0.46. Revenue for the quarter came in at $55.7 million versus the consensus estimate of $55.49 million.

GUIDANCE:

Lemaitre Vascular sees FY2025 EPS of $2.15-$2.32, versus the consensus of $2.16. Lemaitre Vascular sees FY2025 revenue of $235.4-242.8 million, versus the consensus of $240.2 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
• H.C. Wainwright Assumes Alpha Compute Corp. (ALP) at Neutral
• S&P 500 eyes record as retail slump, Iran risk set up pivotal week